Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Veterans | 1 | 2024 | 85 | 0.850 |
Why?
|
| Circulating Tumor DNA | 1 | 2023 | 48 | 0.810 |
Why?
|
| Hematologic Neoplasms | 1 | 2023 | 344 | 0.650 |
Why?
|
| Neoplasms | 5 | 2023 | 3054 | 0.540 |
Why?
|
| Plant Leaves | 2 | 2015 | 78 | 0.520 |
Why?
|
| Brassica rapa | 1 | 2015 | 3 | 0.520 |
Why?
|
| Quantitative Trait Loci | 3 | 2016 | 614 | 0.500 |
Why?
|
| Gene Regulatory Networks | 2 | 2021 | 309 | 0.460 |
Why?
|
| Zebrafish | 3 | 2023 | 320 | 0.460 |
Why?
|
| Genome | 4 | 2023 | 391 | 0.450 |
Why?
|
| Adaptation, Physiological | 2 | 2015 | 314 | 0.450 |
Why?
|
| Phenotype | 6 | 2022 | 2449 | 0.430 |
Why?
|
| Prostatic Neoplasms | 1 | 2024 | 1734 | 0.410 |
Why?
|
| Genotype | 2 | 2017 | 1853 | 0.390 |
Why?
|
| Receptors, Glucocorticoid | 3 | 2019 | 135 | 0.380 |
Why?
|
| Databases, Genetic | 2 | 2021 | 269 | 0.340 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 2 | 2017 | 14 | 0.300 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 1281 | 0.300 |
Why?
|
| Genomics | 5 | 2021 | 775 | 0.300 |
Why?
|
| Gene Expression Profiling | 4 | 2021 | 1446 | 0.280 |
Why?
|
| Mutation | 5 | 2024 | 4160 | 0.270 |
Why?
|
| Genetic Variation | 3 | 2021 | 1380 | 0.260 |
Why?
|
| Receptors, Estrogen | 2 | 2019 | 394 | 0.260 |
Why?
|
| Software | 3 | 2022 | 667 | 0.250 |
Why?
|
| Neuroblastoma | 2 | 2021 | 400 | 0.250 |
Why?
|
| Genomic Instability | 2 | 2022 | 83 | 0.230 |
Why?
|
| Liquid Biopsy | 1 | 2023 | 36 | 0.210 |
Why?
|
| Thymocytes | 1 | 2022 | 31 | 0.200 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2022 | 80 | 0.200 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2022 | 12 | 0.200 |
Why?
|
| Cloud Computing | 1 | 2022 | 13 | 0.200 |
Why?
|
| Data Accuracy | 1 | 2022 | 32 | 0.200 |
Why?
|
| Antitubercular Agents | 1 | 2022 | 53 | 0.200 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 136 | 0.200 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 54 | 0.190 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2022 | 52 | 0.190 |
Why?
|
| Translocation, Genetic | 1 | 2022 | 265 | 0.190 |
Why?
|
| Whole Genome Sequencing | 1 | 2022 | 102 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 2411 | 0.190 |
Why?
|
| Genome, Bacterial | 1 | 2022 | 149 | 0.180 |
Why?
|
| Genome, Viral | 1 | 2021 | 82 | 0.180 |
Why?
|
| DNA Methylation | 3 | 2021 | 663 | 0.180 |
Why?
|
| beta Catenin | 1 | 2022 | 266 | 0.180 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 31 | 0.180 |
Why?
|
| Humans | 24 | 2024 | 89613 | 0.170 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 282 | 0.170 |
Why?
|
| Medical Oncology | 1 | 2024 | 382 | 0.170 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2022 | 449 | 0.170 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 476 | 0.170 |
Why?
|
| Serine Endopeptidases | 1 | 2020 | 146 | 0.170 |
Why?
|
| Nicotinamide N-Methyltransferase | 1 | 2019 | 6 | 0.170 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2022 | 195 | 0.170 |
Why?
|
| Precision Medicine | 1 | 2024 | 409 | 0.160 |
Why?
|
| Retrospective Studies | 2 | 2024 | 9127 | 0.160 |
Why?
|
| Haplotypes | 2 | 2023 | 637 | 0.160 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2019 | 37 | 0.160 |
Why?
|
| MicroRNAs | 2 | 2021 | 555 | 0.150 |
Why?
|
| Vitiligo | 1 | 2017 | 17 | 0.150 |
Why?
|
| Endophenotypes | 1 | 2017 | 18 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2022 | 402 | 0.150 |
Why?
|
| Proteomics | 1 | 2019 | 231 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 262 | 0.140 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2016 | 36 | 0.140 |
Why?
|
| Chromatin | 1 | 2019 | 402 | 0.130 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2016 | 51 | 0.130 |
Why?
|
| Brachypodium | 1 | 2016 | 7 | 0.130 |
Why?
|
| Cysteine Endopeptidases | 1 | 2016 | 87 | 0.130 |
Why?
|
| Personality | 1 | 2017 | 134 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 868 | 0.130 |
Why?
|
| Penile Implantation | 1 | 2016 | 14 | 0.130 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2016 | 75 | 0.130 |
Why?
|
| Penile Prosthesis | 1 | 2016 | 25 | 0.130 |
Why?
|
| Penis | 1 | 2016 | 61 | 0.130 |
Why?
|
| Subcutaneous Fat | 1 | 2015 | 22 | 0.130 |
Why?
|
| Immunotherapy | 1 | 2021 | 688 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 135 | 0.130 |
Why?
|
| Prognosis | 5 | 2022 | 3785 | 0.130 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2016 | 201 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 319 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 305 | 0.120 |
Why?
|
| Peritoneal Neoplasms | 1 | 2016 | 181 | 0.120 |
Why?
|
| Zebrafish Proteins | 1 | 2016 | 149 | 0.120 |
Why?
|
| Ecotype | 1 | 2014 | 7 | 0.120 |
Why?
|
| Panicum | 1 | 2014 | 5 | 0.120 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 571 | 0.120 |
Why?
|
| Exome | 1 | 2015 | 131 | 0.120 |
Why?
|
| Chlamydomonas reinhardtii | 1 | 2014 | 19 | 0.120 |
Why?
|
| Antigens, Neoplasm | 1 | 2016 | 334 | 0.120 |
Why?
|
| Water | 1 | 2016 | 284 | 0.120 |
Why?
|
| Genetic Fitness | 1 | 2014 | 38 | 0.120 |
Why?
|
| Reproductive Isolation | 1 | 2014 | 30 | 0.120 |
Why?
|
| Impulsive Behavior | 1 | 2017 | 287 | 0.110 |
Why?
|
| Phylogeny | 4 | 2022 | 1192 | 0.110 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 3021 | 0.110 |
Why?
|
| Ovarian Neoplasms | 2 | 2019 | 768 | 0.110 |
Why?
|
| Substance-Related Disorders | 1 | 2017 | 418 | 0.110 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 582 | 0.100 |
Why?
|
| Germ-Line Mutation | 1 | 2015 | 346 | 0.100 |
Why?
|
| Male | 8 | 2024 | 42488 | 0.100 |
Why?
|
| Melanoma | 1 | 2016 | 468 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 2582 | 0.100 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 2763 | 0.100 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 589 | 0.100 |
Why?
|
| Hypoxia | 1 | 2016 | 656 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 1983 | 0.090 |
Why?
|
| National Cancer Institute (U.S.) | 2 | 2021 | 71 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 1221 | 0.090 |
Why?
|
| Molecular Sequence Annotation | 2 | 2021 | 71 | 0.090 |
Why?
|
| Datasets as Topic | 2 | 2020 | 75 | 0.080 |
Why?
|
| Inflammation | 1 | 2015 | 975 | 0.080 |
Why?
|
| Female | 11 | 2021 | 46401 | 0.080 |
Why?
|
| Quality of Life | 1 | 2017 | 1673 | 0.080 |
Why?
|
| Biological Evolution | 1 | 2016 | 967 | 0.080 |
Why?
|
| Genome, Human | 2 | 2021 | 791 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2022 | 2878 | 0.060 |
Why?
|
| Pandemics | 2 | 2021 | 777 | 0.060 |
Why?
|
| Animals | 5 | 2023 | 27481 | 0.060 |
Why?
|
| Genetic Markers | 2 | 2016 | 476 | 0.060 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2019 | 488 | 0.060 |
Why?
|
| United States | 3 | 2021 | 7050 | 0.060 |
Why?
|
| Protein Binding | 2 | 2019 | 1491 | 0.060 |
Why?
|
| Neoplasm Metastasis | 2 | 2019 | 1064 | 0.060 |
Why?
|
| Disease Progression | 2 | 2019 | 1463 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2019 | 1158 | 0.050 |
Why?
|
| Chromosomes | 1 | 2023 | 98 | 0.050 |
Why?
|
| Computational Biology | 2 | 2016 | 550 | 0.050 |
Why?
|
| Chromosome Mapping | 2 | 2016 | 1074 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2019 | 2884 | 0.050 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2022 | 66 | 0.050 |
Why?
|
| Immunoglobulins | 1 | 2022 | 143 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2022 | 126 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2022 | 150 | 0.050 |
Why?
|
| Exons | 1 | 2023 | 453 | 0.050 |
Why?
|
| Chemokine CCL3 | 1 | 2021 | 12 | 0.050 |
Why?
|
| Transcriptome | 2 | 2016 | 655 | 0.050 |
Why?
|
| Adult | 5 | 2019 | 26704 | 0.050 |
Why?
|
| Glutathione Transferase | 1 | 2021 | 112 | 0.050 |
Why?
|
| RNA, Long Noncoding | 1 | 2022 | 120 | 0.050 |
Why?
|
| Viruses | 1 | 2021 | 78 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 237 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2021 | 116 | 0.040 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 182 | 0.040 |
Why?
|
| Controlled Before-After Studies | 1 | 2019 | 3 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2021 | 187 | 0.040 |
Why?
|
| Health Information Exchange | 1 | 2019 | 12 | 0.040 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2019 | 9 | 0.040 |
Why?
|
| S-Adenosylmethionine | 1 | 2019 | 17 | 0.040 |
Why?
|
| Niacinamide | 1 | 2019 | 98 | 0.040 |
Why?
|
| Risk Factors | 2 | 2021 | 5517 | 0.040 |
Why?
|
| Middle Aged | 4 | 2020 | 26012 | 0.040 |
Why?
|
| HLA Antigens | 1 | 2020 | 227 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 237 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 592 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2022 | 2063 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 484 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2021 | 1498 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2019 | 508 | 0.040 |
Why?
|
| Base Sequence | 1 | 2021 | 2329 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 284 | 0.040 |
Why?
|
| Histones | 1 | 2019 | 333 | 0.030 |
Why?
|
| Macrophages | 1 | 2020 | 578 | 0.030 |
Why?
|
| Mice | 2 | 2022 | 11832 | 0.030 |
Why?
|
| HLA-A Antigens | 1 | 2016 | 40 | 0.030 |
Why?
|
| Databases, Nucleic Acid | 1 | 2016 | 41 | 0.030 |
Why?
|
| Cloning, Organism | 1 | 2016 | 19 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2021 | 727 | 0.030 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2016 | 14 | 0.030 |
Why?
|
| Penile Induration | 1 | 2016 | 7 | 0.030 |
Why?
|
| Mental Health | 1 | 2017 | 179 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 105 | 0.030 |
Why?
|
| Response Elements | 1 | 2016 | 69 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 294 | 0.030 |
Why?
|
| Cadaver | 1 | 2016 | 186 | 0.030 |
Why?
|
| Young Adult | 2 | 2017 | 6368 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2016 | 276 | 0.030 |
Why?
|
| Behavior, Addictive | 1 | 2017 | 134 | 0.030 |
Why?
|
| Health Status | 1 | 2017 | 371 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 137 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2016 | 215 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2016 | 3397 | 0.030 |
Why?
|
| Adolescent | 2 | 2017 | 9305 | 0.030 |
Why?
|
| Synteny | 1 | 2014 | 28 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 1048 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2014 | 171 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 849 | 0.030 |
Why?
|
| Adipocytes | 1 | 2015 | 163 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 848 | 0.030 |
Why?
|
| Hybridization, Genetic | 1 | 2014 | 106 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2015 | 343 | 0.030 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2014 | 124 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2017 | 539 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 516 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2016 | 714 | 0.030 |
Why?
|
| Gene-Environment Interaction | 1 | 2014 | 117 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1668 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1862 | 0.030 |
Why?
|
| Internet | 1 | 2015 | 321 | 0.030 |
Why?
|
| Aged | 2 | 2020 | 19158 | 0.030 |
Why?
|
| Gene Expression | 1 | 2016 | 1309 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 2384 | 0.020 |
Why?
|
| Genetics, Population | 1 | 2014 | 407 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 2003 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 1686 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2016 | 1529 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2646 | 0.020 |
Why?
|
| Algorithms | 1 | 2015 | 1903 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 6771 | 0.010 |
Why?
|